New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
MorphoSys AG
MOR.DE
Shape
US Flag

XETRA

Unprofitable

Unprofitable

3B

Biotechnology

Next Earning date - 29 Oct 2024

3B

Biotechnology

Next Earning date - 29 Oct 2024

67.25EUR
Shape-0.45 ( -0.66%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-94%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

4%

Quote Panel

Shape
Updated October 29, 2024
1W % 1M % 3M -0.96 % 1Y 125.29 %

Key Metrics

Shape
  • Market Cap

    2.53B


  • Shares Outstanding

    37.66M


  • Share in Float

    18.44M


  • Dividende

    0


  • Earning Date

    29 Oct 2024


  • Price Target

    67.25


  • Average Volume

    70878


  • Beta

    0.662


  • Range

    14.52-69.75


  • Industry

    Biotechnology


  • Website

    https://www.morphosys.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

12.44x

P/S Ratio

-9.67x

P/B Ratio

-1.0

Debt/Equity

-226.1%

Net Margin

$-5.5

EPS

How MOR.DE compares to sector?

P/E Ratio

Relative Strength

Shape

MOR.DE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$322M

Shape1071%

2025-Revenue

$2.19

Shape74%

2025-EPS

$90M

Shape66%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-6.88
vs 0.59

Q3.22

arrow
arrow

N/A

-3.60
vs -3.30

Q4.22

arrow
arrow

N/A

-3.60
vs -11.16

Q1.23

arrow
arrow

+125%

1.32
vs -5.19

Q2.23

arrow
arrow

N/A

-2.16
vs -6.88

Q3.23

arrow
arrow

N/A

-3.50
vs -3.60

Q4.23

arrow
arrow

+140%

1.45
vs -3.60

Q1.24

arrow
arrow

N/A

-8.16
vs 1.32

Q3.24

arrow
arrow

N/A

-1.24
vs -3.50

Q4.24

arrow
arrow

N/A

-1.02
vs 1.45

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+56%

59.4M  vs 38.2M

Q3.22

arrow
arrow

+132%

95.7M  vs 41.2M

Q4.22

arrow
arrow

+54%

81.7M  vs 52.9M

Q1.23

arrow
arrow

+50%

62.3M  vs 41.5M

Q2.23

arrow
arrow

-11%

53.2M  vs 59.4M

Q3.23

arrow
arrow

-33%

63.8M  vs 95.7M

Q4.23

arrow
arrow

-28%

59.1M  vs 81.7M

Q1.24

arrow
arrow

-56%

27.5M  vs 62.3M

Q3.24

arrow
arrow

-54%

29.3M  vs 63.8M

Q4.24

arrow
arrow

-45%

32.7M  vs 59.1M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

+856%

8.56
vs -1.25

Q3.22

arrow
arrow

+143%

1.43
vs 8.56

Q4.22

arrow
arrow

+209%

2.09
vs 1.43

Q1.23

arrow
arrow

-45%

-0.45
vs 2.09

Q2.23

arrow
arrow

-234%

-2.34
vs -0.45

Q3.23

arrow
arrow

+179%

1.79
vs -2.34

Q4.23

arrow
arrow

+98%

0.98
vs 1.79

Q1.24

arrow
arrow

+120%

1.2
vs 0.98

Institutionnal OwnershipShape

status-upQoQ

Q1.18

arrow
arrow

1

1
vs 1

NA

Q2.18

arrow
arrow

1

1
vs 1

NA

Q3.18

arrow
arrow

1

1
vs 1

NA

Q4.18

arrow
arrow

1

1
vs 1

NA

Q1.19

arrow
arrow

1

1
vs 1

NA

Q2.19

arrow
arrow

1

1
vs 1

NA

Q4.19

arrow
arrow

2

2
vs NA

NA

Q1.20

arrow
arrow

1

1
vs 2

-50%

Earnings Growth

Latest News